We are live on ! Find out more
SURG icon

SurgePays

13 hedge funds and large institutions have $2.25M invested in SurgePays in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more capital invested

Capital invested by funds: $1.12M → $2.25M (+$1.13M)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 1213 (+1)

0.05% less ownership

Funds ownership: 4.62%4.57% (-0.05%)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
4
Closed
3
Calls
Puts
Net Calls
Net Calls Change

SURG Hedge Fund Activity: Q1 2022 in Review

13 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in SurgePays (SURG) for Q1 2022, worth a combined $2.25M — up 100% from $1.12M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SURG positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $92K. The largest seller was Vanguard Group, cutting an estimated $178K.

  • 13 institutional investors held SurgePays (SURG) as of Q1 2022, up from 12 in Q4 2021.
  • Funds reported $2.25M of SurgePays stock for Q1 2022, up 100% quarter-over-quarter.
  • 4 funds opened new SurgePays positions in Q1 2022 and 3 closed out, a net change of +1 holder.
  • The largest SurgePays buyer in Q1 2022 was Commonwealth Equity Services, an estimated $92K added.
  • The largest SurgePays seller in Q1 2022 was Vanguard Group, an estimated $178K sold.

Based on aggregated 13F filings for Q1 2022.